NCT06508047

Brief Summary

Evaluating the Accuracy of a Web-Based Application - Vital Sign Measurement Platform. This single-arm cohort, open-label study is designed to evaluate the accuracy of a web-based application designed for measurements of vital signs including respiratory rate (RR). The purpose of the study is to conduct accuracy validation when compared to a FDA-cleared/approved vital sign monitoring device (reference device).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

July 16, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 18, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 22, 2024

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

March 18, 2026

Completed
Last Updated

March 18, 2026

Status Verified

February 1, 2026

Enrollment Period

1 month

First QC Date

July 12, 2024

Results QC Date

June 12, 2025

Last Update Submit

February 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Respiratory Rate Accuracy

    The endpoint of interest is accuracy as measured by the Accuracy root-mean-square (Arms) difference between the Device Under Test (DUT) and the Reference (Ref) Respiratory Rate as counted using the End Tidal Carbon Dioxide scored waveform by counting the respiratory peaks per minute for all stable respiratory periods.

    60 seconds

Study Arms (1)

Informed Vital Core App

All subjects assigned to a single arm, respiration rate measurement will be collected, calculated, and displayed on the web based application. Conventional Capnography will also be used to collect and display the respiratory rate at the same time as the Informed Vital Core App.

Device: Informed Vital Core App

Interventions

Informed Vital Core App will be initiated by the study staff to take a measurement, which takes 60 seconds to calculate and report a breathing rate value.

Informed Vital Core App

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

At least 30% of the participants will be male At least 30% of the participants will be female At least 33% of the participants will be with BMI between 25.0 to 29.9 kg/m2 (overweight) At least 33% of the participants will be with BMI \> 30.0 kg/m2 (obese) At least 15% of participants will have a light skin tone (Fitzpatrick Scale 1 or 2) At least 15% of participants will have a medium skin tone (Fitzpatrick Scale 3 or 4) At least 15% of participants will have a dark skin tone (Fitzpatrick Scale 5 or 6) The study will attempt to enroll a race/ethnicity distribution similar to population demographics consistent with the 2020 US Census Data At least 5 participants will have a history of smoking At least 10 participants with chronic conditions (self-reported):

You may qualify if:

  • Participants must have the ability to understand and provide written informed consent or have legally authorized representative consent to participate.
  • Participant must be ≥22 years of age
  • Participant must be willing and able to comply with study procedures and duration
  • Participants or legally authorized representative must be able to read or write in English

You may not qualify if:

  • Participants who refuse or are unable to sign an informed written consent for study
  • Participants evaluated by the Investigator and Clinical Staff and found to be medically unsuitable or have self-reported health conditions that are currently unstable as identified in the Health Assessment Form and Health Screening
  • Compromised circulation, injury, or physical malformation the Region of Interest (ROI) which would limit the ability to test ROI needed for the study. (Note: Certain malformations may still allow participants to participate if the condition is noted and would not affect the particular areas utilized.)
  • Participants with severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors, ECG electrodes, or other medical sensors (self-reported)
  • Other known health condition, should be considered upon disclosure in health assessment form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Element Materials Techonology

Louisville, Colorado, 80027, United States

Location

Results Point of Contact

Title
Jeremy Markovich
Organization
Mindset Medical

Study Officials

  • Monica Rabanal

    Element Materials Technology

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2024

First Posted

July 18, 2024

Study Start

July 16, 2024

Primary Completion

August 22, 2024

Study Completion

August 22, 2024

Last Updated

March 18, 2026

Results First Posted

March 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations